60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
2.390
-0.030 (-1.24%)
May 13, 2025, 4:00 PM - Market closed

SXTP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.680.250.516.352.55
Revenue Growth (YoY)
168.70%-50.40%-91.95%149.18%-
Cost of Revenue
3.610.670.966.361.51
Gross Profit
-2.93-0.41-0.45-0.011.04
Selling, General & Admin
5.024.241.31.121.46
Research & Development
1.760.5---
Operating Expenses
6.784.741.31.121.46
Operating Income
-9.71-5.15-1.75-1.12-0.42
Interest Expense
-0.01-2.29-3.99-3.17-2.63
Other Non Operating Income (Expenses)
1.77-0.47-0.56-0-
EBT Excluding Unusual Items
-7.96-7.91-6.3-4.3-3.05
Other Unusual Items
-4.10.120.04-
Pretax Income
-7.96-3.81-6.18-4.26-3.05
Income Tax Expense
00000
Earnings From Continuing Operations
-7.96-3.81-6.18-4.26-3.05
Minority Interest in Earnings
0.010.05-00.010.01
Net Income
-7.95-3.77-6.18-4.25-3.03
Preferred Dividends & Other Adjustments
0.480.22---
Net Income to Common
-8.43-3.99-6.18-4.25-3.03
Shares Outstanding (Basic)
00019-
Shares Outstanding (Diluted)
00019-
Shares Change (YoY)
585.50%68.05%-99.79%--
EPS (Basic)
-18.55-60.11-156.65-0.23-
EPS (Diluted)
-18.55-60.11-156.65-0.23-
Free Cash Flow
-5.75-4.6-1.01-0.65-0.17
Free Cash Flow Per Share
-12.65-69.38-25.59-0.04-
Gross Margin
--163.01%-87.39%-0.14%40.78%
Operating Margin
-1425.85%-2032.78%-342.41%-17.69%-16.40%
Profit Margin
-1237.32%-1572.10%-1209.23%-66.93%-119.00%
Free Cash Flow Margin
-844.19%-1814.28%-197.57%-10.27%-6.56%
EBITDA
-9.66-5.1-1.72-1.09-0.39
EBITDA Margin
----17.21%-15.31%
D&A For EBITDA
0.050.050.030.030.03
EBIT
-9.71-5.15-1.75-1.12-0.42
EBIT Margin
----17.69%-16.40%
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q